UBS Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Buy
409,757
+296,389
+261% +$9.34M ﹤0.01% 3079
2025
Q4
$3.34M Sell
113,368
-373,028
-77% -$10.4M ﹤0.01% 4443
2025
Q3
$12.3M Buy
486,396
+269,676
+124% +$6.57M ﹤0.01% 3074
2025
Q2
$5.2M Sell
216,720
-432,750
-67% -$10M ﹤0.01% 3845
2025
Q1
$14.9M Buy
649,470
+308,307
+90% +$7.44M ﹤0.01% 2635
2024
Q4
$8.64M Buy
341,163
+72,337
+27% +$1.83M ﹤0.01% 3223
2024
Q3
$6.7M Sell
268,826
-7,912
-3% -$234K ﹤0.01% 2765
2024
Q2
$8.21M Buy
276,738
+166,749
+152% +$4.63M ﹤0.01% 2398
2024
Q1
$3.32M Buy
109,989
+52,414
+91% +$1.45M ﹤0.01% 3408
2023
Q4
$1.65M Buy
57,575
+27,845
+94% +$818K ﹤0.01% 4025
2023
Q3
$1.1M Sell
29,730
-1,330
-4% -$50.8K ﹤0.01% 3981
2023
Q2
$1.21M Sell
31,060
-227,643
-88% -$8.92M ﹤0.01% 4050
2023
Q1
$9.45M Buy
258,703
+664
+0.3% +$21K ﹤0.01% 1935
2022
Q4
$7.95M Buy
+258,039
New +$8.01M ﹤0.01% 2088

Other funds holding RTO

UBS Group's RTO Position: Q1 2026 in Review

UBS Group increased its Rentokil (RTO) stake by 261% in Q1 2026, buying an estimated $9.34M and bringing the position to 409,757 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

UBS Group first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $14.9M in Q1 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • UBS Group held 409,757 shares of Rentokil worth $12.9M as of Q1 2026.
  • UBS Group bought 296,389 Rentokil shares in Q1 2026, an estimated $9.34M.
  • Rentokil made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3079 holding.
  • UBS Group first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
  • UBS Group's Rentokil position peaked at $14.9M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.